JPMorgan Chase & Co. Sells 103,426 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR)
JPMorgan Chase & Co. reduced its position in Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 73.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,065 shares of the company’s stock after selling 103,426 shares during the quarter. JPMorgan Chase […]
JPMorgan Chase & Co. reduced its position in Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 73.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,065 shares of the company’s stock after selling 103,426 shares during the quarter. JPMorgan Chase […]
